Enzo Biochem explains $4.6M loss
Enzo BioChem Inc., Manhattan, biochemical research and development
Quarter: Ended April 30, 2010
Net income: Loss of $4.6 million compared with loss of $4.2 million in the same quarter last year.
Net revenue: $23.8 million compared with $23 million in the year-ago quarter.
Company statement: The company, which has a major division, Enzo Clinical Labs, based in Farmingdale, said selling, general and administrative expenses rose at its life sciences business because it is integrating a new business and changing its product lineup. Also, its clinical lab business spent more on hiring and invested in new tests. - Joseph Mallia
Woman arrested in connection with Nassau stabbing ... How family found out girl, 7, was dead ... Car crashes into Suffolk home ... DOJ asked to investigate mascot ban
Woman arrested in connection with Nassau stabbing ... How family found out girl, 7, was dead ... Car crashes into Suffolk home ... DOJ asked to investigate mascot ban
